Flora Growth Announces Results of 2025 Special Meeting of Shareholders
Rhea-AI Summary
Flora Growth (NASDAQ: FLGC) held a Special Meeting of Shareholders on December 19, 2025 and approved nine proposals including authority to change the company name to ZeroStack Corp., create a new class of preferred shares, and approve an amendment to the 2022 Incentive Compensation Plan.
Key approvals: increase 2022 Plan reserve to 10% of fully diluted common shares, raise Incentive Stock Option cap to the lower of 2,000,000 and outstanding shares, grant stock options to executives, authorize issuances tied to the September 2025 private placement and convertible notes, and permit a forward split between 2:1 and 10:1 within one year.
Positive
- Name-change authority approved with 307,327 For votes
- 2022 Plan reserve increased to 10% of fully diluted common shares
- Incentive Stock Option cap raised to the lower of 2,000,000 and outstanding shares
- Forward split authority 2:1–10:1 approved for one year
- Issuance approvals granted for September 2025 private placement securities and convertible notes
Negative
- Potential dilution from 2022 Plan increase to 10% of fully diluted shares
- Potential dilution from authorized issuances tied to September 2025 private placement convertible notes
- A sizeable broker non-vote block (164,374 shares) on several proposals
Details
News Market Reaction – FLGC
On Dec 22, the first trading day after this news, FLGC closed 3.35% above the previous close.
Data tracked by StockTitan Argus for the Dec 22 session.
Key Figures
- Proposal 1 votes for
- 307,327 votes
- Name change authorization to “ZeroStack Corp.”
- Proposal 2 broker non-votes
- 164,374 non-votes
- Creation of new preferred share class
- Incentive plan prior pool
- 115,385 shares
- Old 2022 Incentive Compensation Plan share reserve
- Incentive plan new limit
- 10% of fully diluted shares
- Revised 2022 Plan share pool cap
- ISO cap
- 2,000,000 options (maximum)
- Upper limit for Incentive Stock Options under 2022 Plan Amendment
- Forward split range
- 2:1 to 10:1
- Authorized forward share split ratio range
- Proposal 8 votes for
- 280,700 votes
- Authority to implement forward share split
- Proposal 5 votes for
- 53,843 votes
- Approval of shares underlying pre-funded warrants and warrants
Historical Context
-
Announced second purchase of $0G tokens expanding decentralized AI treasury.
-
Appointed BitGo as custodian for $0G treasury to enhance security and compliance.
-
Disclosed first major 0G token purchase and outlined AI treasury strategy.
-
Reported $401M funding, including $22.88M from DFDV, to build 0G treasury.
-
Announced regaining compliance with Nasdaq minimum bid price requirement.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
pre-funded warrants financial
convertible note financial
Nasdaq Listing Rules 5635(c) regulatory
Nasdaq Listing Rule 5635(d) regulatory
Articles of Amendment regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Fort Lauderdale, Florida--(Newsfile Corp. - December 19, 2025) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of
Proposal 1: To give the board of directors of the Company (the "Board") the authority, at its discretion, to file Articles of Amendment to the Company's amended and restated Articles of Incorporation to change the name of the Company to "ZeroStack Corp." or to such other name as the Board, in its sole discretion, determines to be appropriate:
| For | Against | Abstentions | ||
| 307,327 | 53,559 | 1,695 |
Proposal 2: To give the Board the authority, at its discretion, to file Articles of Amendment to the Company's amended and restated Articles of Incorporation to create a new class of preferred shares, issuable in series, and to provide for the rights, privileges, restrictions and conditions attaching to the common shares, no par value, of the Company (the "Common Shares") and the preferred shares, as a class:
| Broker | |||||
| For | Against | Abstentions | Non-Votes | ||
| 165,494 | 32,278 | 435 | 164,374 |
Proposal 3: To approve an amendment (the "2022 Plan Amendment") to the Company's 2022 Plan to the Company's 2022 Incentive Compensation Plan, as amended on June 6, 2023, August 14, 2024 and June 30, 2025 (the "2022 Plan"), to (i) increase the number of Common Shares issuable thereunder from 115,385 to
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 167,124 | 30,477 | 606 | 164,374 |
Proposal 4: To approve the grant of stock options to the Company's Chief Executive Officer, Chief Financial Officer and Executive Chairman.
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 166,325 | 30,688 | 1,194 | 164,374 |
Proposal 5: To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of Common Shares underlying pre-funded warrants and warrants sold in the Company's private placement transactions entered into by the Company with certain investors, pursuant to securities purchase agreements, dated on or about September 19, 2025 (the "September 2025 Private Placement"):
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 53,843 | 27,150 | 874 | 164,374 |
Proposal 6: To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of Common Shares underlying the convertible note issued to DeFi Development Corp in the Company's September 2025 Private Placement:
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 53,843 | 27,076 | 897 | 164,374 |
Proposal 7: To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of Common Shares underlying the convertible note issued to Zero Gravity Labs Inc. in the Company's September 2025 Private Placement:
| Broker | ||||||
| For | Against | Abstentions | Non-Votes | |||
| 54,609 | 27,033 | 225 | 164,374 |
Proposal 8: To give the Board the authority, at its discretion, to file Articles of Amendment to the Company's amended and restated Articles of Incorporation to effect a forward share split of the Company's outstanding Common Shares, at a ratio between 2:1 to 10:1, without reducing the authorized number of Common Shares, to be effected, if at all, in the sole discretion of the Board at any time within one year of the date of the Meeting without further approval or authorization of our shareholders:
| For | Against | Abstentions | |||
| 280,700 | 70,061 | 11,820 |
Proposal 9: To approve one or more adjournments or postponements of the Meeting by the Company from time to time to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the Meeting to approve one or more of Proposals Nos. 1-8 at the time of such adjournment or postponement or if otherwise determined by the chairperson of the Meeting to be necessary or appropriate:
| For | Against | Abstentions | |||
| 280,588 | 80,155 | 1,838 |
Based on the foregoing votes, Proposals 1, 2, 3, 4, 5, 6, 7, 8 and 9 were approved. No other matters were considered or voted upon at the Meeting.
About Flora Growth Corp:
Flora Growth Corp., which is set to be rebranded as ZeroStack, is the first and largest decentralized AI treasury company that is investing in the future of AI infrastructure through the
Cautionary Statement Concerning Forward-Looking Statements
This press release may contain "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 24, 2025, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
Investor Contact: ir@zerostack.ai
Media Contact: zerostack@dittopr.co
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278726
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.